ReP USP - Resultado da busca

Artigo de periodico
The anticancer potential of kaempferol: a systematic review based on in vitro studies (2024)
Morais, Everton Freitas de ; Oliveira, Lilianny Querino Rocha de ; Morais, Hannah Gil de Farias ; Medeiros, Maurília Raquel de Souto ; Freitas, Roseana de Almeida ; Rodini, Camila de Oliveira ; Coletta, Ricardo Della
Fonte: Cancers. Unidade: FOB
Assuntos: QUIMIOTERÁPICOS, PRODUTOS NATURAIS, FLAVONOIDES, USOS TERAPÊUTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS, Everton Freitas de et al. The anticancer potential of kaempferol: a systematic review based on in vitro studies. Cancers, v. 16, n. 3, 2024Tradução . . Disponível em: https://doi.org/10.3390/cancers16030585. Acesso em: 06 nov. 2024.
APA
Morais, E. F. de, Oliveira, L. Q. R. de, Morais, H. G. de F., Medeiros, M. R. de S., Freitas, R. de A., Rodini, C. de O., & Coletta, R. D. (2024). The anticancer potential of kaempferol: a systematic review based on in vitro studies. Cancers, 16( 3). doi:10.3390/cancers16030585
NLM
Morais EF de, Oliveira LQR de, Morais HG de F, Medeiros MR de S, Freitas R de A, Rodini C de O, Coletta RD. The anticancer potential of kaempferol: a systematic review based on in vitro studies [Internet]. Cancers. 2024 ; 16( 3):[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers16030585
Vancouver
Morais EF de, Oliveira LQR de, Morais HG de F, Medeiros MR de S, Freitas R de A, Rodini C de O, Coletta RD. The anticancer potential of kaempferol: a systematic review based on in vitro studies [Internet]. Cancers. 2024 ; 16( 3):[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers16030585
Artigo de periodico-carta/editorial
Translational and comparative research on innovative anti-cancer therapies [Editorial] (2023)
Queiroga, Felisbina ; Cogliati, Bruno
Fonte: Cancers. Unidade: FMVZ
Assuntos: NEOPLASIAS, ONCOLOGIA VETERINÁRIA, ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QUEIROGA, Felisbina e COGLIATI, Bruno. Translational and comparative research on innovative anti-cancer therapies [Editorial]. Cancers. Basel: Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo. Disponível em: https://doi.org/10.3390/cancers15041335. Acesso em: 06 nov. 2024. , 2023
APA
Queiroga, F., & Cogliati, B. (2023). Translational and comparative research on innovative anti-cancer therapies [Editorial]. Cancers. Basel: Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo. doi:10.3390/cancers15041335
NLM
Queiroga F, Cogliati B. Translational and comparative research on innovative anti-cancer therapies [Editorial] [Internet]. Cancers. 2023 ; 15( 4): 1-3.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15041335
Vancouver
Queiroga F, Cogliati B. Translational and comparative research on innovative anti-cancer therapies [Editorial] [Internet]. Cancers. 2023 ; 15( 4): 1-3.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15041335
Artigo de periodico
The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells (2023)
Lima, Keli ; Miranda, Lívia Bassani Lins De ; Garnique, Anali Del Milagro Bernabe ; Almeida, Bruna Oliveira de ; Nascimento, Mariane Cristina do; Alcântara, Guilherme Augusto Sousa; Machado-Santelli, Glaucia Maria ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Fonte: Cancers. Unidades: ICB, FM
Assuntos: BIOLOGIA CELULAR, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS PANCREÁTICAS, INIBIDORES DE ENZIMAS, ANTINEOPLÁSICOS, DANO AO DNA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli et al. The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells. Cancers, v. 15, n. 15, p. 14 , 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15153866. Acesso em: 06 nov. 2024.
APA
Lima, K., Miranda, L. B. L. D., Garnique, A. D. M. B., Almeida, B. O. de, Nascimento, M. C. do, Alcântara, G. A. S., et al. (2023). The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells. Cancers, 15( 15), 14 . doi:10.3390/cancers15153866
NLM
Lima K, Miranda LBLD, Garnique ADMB, Almeida BO de, Nascimento MC do, Alcântara GAS, Machado-Santelli GM, Rego EM, Machado Neto JA. The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells [Internet]. Cancers. 2023 ; 15( 15): 14 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15153866
Vancouver
Lima K, Miranda LBLD, Garnique ADMB, Almeida BO de, Nascimento MC do, Alcântara GAS, Machado-Santelli GM, Rego EM, Machado Neto JA. The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells [Internet]. Cancers. 2023 ; 15( 15): 14 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15153866
Artigo de periodico
Inhibitory effects of alpha-connexin carboxyl-terminal peptide on canine mammary epithelial cells: a study on benign and malignant phenotypes (2023)
Fonseca, Ivone Izabel Mackowiak da ; Nagamine, Márcia Kazumi ; Sato, Ayami ; Rossatto Junior, Carlos Alberto ; Yeh, Elizabeth Shinmay; Dagli, Maria Lúcia Zaidan
Fonte: Cancers. Unidade: FMVZ
Assuntos: CÃES, CONEXINAS, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Ivone Izabel Mackowiak da et al. Inhibitory effects of alpha-connexin carboxyl-terminal peptide on canine mammary epithelial cells: a study on benign and malignant phenotypes. Cancers, v. 16, n. 4, p. 1-19, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers16040820. Acesso em: 06 nov. 2024.
APA
Fonseca, I. I. M. da, Nagamine, M. K., Sato, A., Rossatto Junior, C. A., Yeh, E. S., & Dagli, M. L. Z. (2023). Inhibitory effects of alpha-connexin carboxyl-terminal peptide on canine mammary epithelial cells: a study on benign and malignant phenotypes. Cancers, 16( 4), 1-19. doi:10.3390/cancers16040820
NLM
Fonseca IIM da, Nagamine MK, Sato A, Rossatto Junior CA, Yeh ES, Dagli MLZ. Inhibitory effects of alpha-connexin carboxyl-terminal peptide on canine mammary epithelial cells: a study on benign and malignant phenotypes [Internet]. Cancers. 2023 ; 16( 4): 1-19.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers16040820
Vancouver
Fonseca IIM da, Nagamine MK, Sato A, Rossatto Junior CA, Yeh ES, Dagli MLZ. Inhibitory effects of alpha-connexin carboxyl-terminal peptide on canine mammary epithelial cells: a study on benign and malignant phenotypes [Internet]. Cancers. 2023 ; 16( 4): 1-19.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers16040820
Artigo de periodico
Anthocyanins reduce cell invasion and migration through Akt/mTOR downregulation and apoptosis activation in triple-negative breast cancer cells: a systematic review and meta-analysis (2023)
Rabelo, Ana Carolina Silveira ; Guerreiro, Caroline de Aquino ; Shinzato, Vivian Izumi; Ong, Thomas Prates ; Noratto, Giuliana
Fonte: Cancers. Unidade: FCF
Assuntos: NEOPLASIAS MAMÁRIAS, CEREJA, ARROZ, PRODUTOS NATURAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RABELO, Ana Carolina Silveira et al. Anthocyanins reduce cell invasion and migration through Akt/mTOR downregulation and apoptosis activation in triple-negative breast cancer cells: a systematic review and meta-analysis. Cancers, v. 15, p. 1-13 art. 2300, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15082300. Acesso em: 06 nov. 2024.
APA
Rabelo, A. C. S., Guerreiro, C. de A., Shinzato, V. I., Ong, T. P., & Noratto, G. (2023). Anthocyanins reduce cell invasion and migration through Akt/mTOR downregulation and apoptosis activation in triple-negative breast cancer cells: a systematic review and meta-analysis. Cancers, 15, 1-13 art. 2300. doi:10.3390/cancers15082300
NLM
Rabelo ACS, Guerreiro C de A, Shinzato VI, Ong TP, Noratto G. Anthocyanins reduce cell invasion and migration through Akt/mTOR downregulation and apoptosis activation in triple-negative breast cancer cells: a systematic review and meta-analysis [Internet]. Cancers. 2023 ; 15 1-13 art. 2300.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15082300
Vancouver
Rabelo ACS, Guerreiro C de A, Shinzato VI, Ong TP, Noratto G. Anthocyanins reduce cell invasion and migration through Akt/mTOR downregulation and apoptosis activation in triple-negative breast cancer cells: a systematic review and meta-analysis [Internet]. Cancers. 2023 ; 15 1-13 art. 2300.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15082300
Artigo de periodico
Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial (2023)
Lepski, Guilherme ; Bergami-Santos, Patricia C. ; Pinho, Mariana P. ; Chauca-Torres, Nadia E. ; Evangelista, Gabriela C. M. ; Teixeira, Sarah F. ; Flatow, Elizabeth ; Oliveira, Jaqueline V. de ; Fogolin, Carla ; Peres, Nataly ; Arévalo, Analía ; Alves, Venâncio A. F. ; Barbuto, José Alexandre Marzagão
Fonte: Cancers. Unidades: FM, ICB
Assuntos: IMUNOLOGIA, NEOPLASIAS CEREBRAIS, GLIOMA, IMUNOTERAPIA, ADJUVANTES IMUNOLÓGICOS, CÉLULAS DENDRÍTICAS, ASTROCITOMA, CÉLULAS CULTIVADAS DE TUMOR, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEPSKI, Guilherme et al. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial. Cancers, v. 15, n. 4, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15041239. Acesso em: 06 nov. 2024.
APA
Lepski, G., Bergami-Santos, P. C., Pinho, M. P., Chauca-Torres, N. E., Evangelista, G. C. M., Teixeira, S. F., et al. (2023). Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial. Cancers, 15( 4), 1-12. doi:10.3390/cancers15041239
NLM
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, Oliveira JV de, Fogolin C, Peres N, Arévalo A, Alves VAF, Barbuto JAM. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial [Internet]. Cancers. 2023 ; 15( 4): 1-12.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15041239
Vancouver
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, Oliveira JV de, Fogolin C, Peres N, Arévalo A, Alves VAF, Barbuto JAM. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial [Internet]. Cancers. 2023 ; 15( 4): 1-12.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15041239
Artigo de periodico
GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status (2023)
Moretti, Isabele Fattori ; Lerario, Antonio Marcondes ; Sola, Paula Rodrigues ; Silva, Janaína Macedo da; Baptista, Mauricio da Silva ; Palmisano, Giuseppe ; Shinjo, Sueli Mieko Oba ; Marie, Suely Kazue Nagahashi
Fonte: Cancers. Unidades: FM, IQ, ICB
Assuntos: PARASITOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS CEREBRAIS, GLIOMA, LIPOPOLISSACARÍDEOS, ANTIOXIDANTES, ANTIDIABÉTICOS (HIPOGLICEMIANTES), ESTRESSE OXIDATIVO, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORETTI, Isabele Fattori et al. GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status. Cancers, v. 15, n. 3, p. 1-18, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15030587. Acesso em: 06 nov. 2024.
APA
Moretti, I. F., Lerario, A. M., Sola, P. R., Silva, J. M. da, Baptista, M. da S., Palmisano, G., et al. (2023). GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status. Cancers, 15( 3), 1-18. doi:10.3390/cancers15030587
NLM
Moretti IF, Lerario AM, Sola PR, Silva JM da, Baptista M da S, Palmisano G, Shinjo SMO, Marie SKN. GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status [Internet]. Cancers. 2023 ; 15( 3): 1-18.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15030587
Vancouver
Moretti IF, Lerario AM, Sola PR, Silva JM da, Baptista M da S, Palmisano G, Shinjo SMO, Marie SKN. GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status [Internet]. Cancers. 2023 ; 15( 3): 1-18.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15030587
Artigo de periodico
Acute Myeloid Leukemia expresses a specific group of olfactory receptors (2023)
Guardia, Gabriela D. A; Naressi, Rafaella G ; Buzzato, Vanessa C; Costa, Juliana B. da; Zalcberg, Ilana; Ramires, Jordana; Malnic, Bettina ; Gutiyama, Luciana M; Galante, Pedro A. F.
Fonte: Cancers. Unidade: IQ
Assuntos: LEUCEMIA MIELOIDE AGUDA, BIOMARCADORES, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUARDIA, Gabriela D. A et al. Acute Myeloid Leukemia expresses a specific group of olfactory receptors. Cancers, v. 15, p. 1-21 art. 3073, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15123073. Acesso em: 06 nov. 2024.
APA
Guardia, G. D. A., Naressi, R. G., Buzzato, V. C., Costa, J. B. da, Zalcberg, I., Ramires, J., et al. (2023). Acute Myeloid Leukemia expresses a specific group of olfactory receptors. Cancers, 15, 1-21 art. 3073. doi:10.3390/cancers15123073
NLM
Guardia GDA, Naressi RG, Buzzato VC, Costa JB da, Zalcberg I, Ramires J, Malnic B, Gutiyama LM, Galante PAF. Acute Myeloid Leukemia expresses a specific group of olfactory receptors [Internet]. Cancers. 2023 ; 15 1-21 art. 3073.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15123073
Vancouver
Guardia GDA, Naressi RG, Buzzato VC, Costa JB da, Zalcberg I, Ramires J, Malnic B, Gutiyama LM, Galante PAF. Acute Myeloid Leukemia expresses a specific group of olfactory receptors [Internet]. Cancers. 2023 ; 15 1-21 art. 3073.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15123073
Artigo de periodico
Diagnosis, prognosis, and treatment of canine hemangiosarcoma: a review based on a consensus organized by the Brazilian Association of Veterinary Oncology, ABROVET (2023)
De Nardi, Andrigo Barboza ; Gomes, Cristina de Oliveira Massoco-Salles ; Alves, Carlos Eduardo Fonseca ; Paiva, Felipe Noleto de ; Linhares, Laís Calazans Menescal ; Carra, Gabriel João Unger ; Horta, Rodrigo dos Santos ; Sueiro, Felipe Augusto Ruiz ; Jark, Paulo Cesar; Nishiya, Adriana Tomoko; Vasconcellos, Carmen Helena de Carvalho; Ubukata, Rodrigo; Batschinski, Karen; Sobral, Renata Afonso; Fernandes, Simone Crestoni ; Biondi, Luiz Roberto ; Strefezzi, Ricardo de Francisco ; Matera, Júlia Maria ; Rangel, Marcelo Monte Mór; Anjos, Denner Santos dos ; Brunner, Carlos Henrique Maciel; Amorim, Renee Laufer ; Cadrobbi, Karine Germano; Cirillo, Juliana Vieira; Martins, Mauro Caldas; Reis Filho, Nazilton de Paula; Lessa, Diego Fernando Silva; Portela, Roberta; Carneiro, Carolina Scarpa; Lucas, Silvia Regina Ricci ; Fukumasu, Heidge ; Feliciano, Marcus Antônio Rossi ; Quitzan, Juliany Gomes; Dagli, Maria Lúcia Zaidan
Fonte: Cancers. Unidades: FMVZ, FZEA
Assuntos: CÃES, HEMANGIOSARCOMA ANIMAL, QUIMIOTERAPIA, HISTOPATOLOGIA ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE NARDI, Andrigo Barboza et al. Diagnosis, prognosis, and treatment of canine hemangiosarcoma: a review based on a consensus organized by the Brazilian Association of Veterinary Oncology, ABROVET. Cancers, v. 15, n. 7, p. 1-36, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15072025. Acesso em: 06 nov. 2024.
APA
De Nardi, A. B., Gomes, C. de O. M. -S., Alves, C. E. F., Paiva, F. N. de, Linhares, L. C. M., Carra, G. J. U., et al. (2023). Diagnosis, prognosis, and treatment of canine hemangiosarcoma: a review based on a consensus organized by the Brazilian Association of Veterinary Oncology, ABROVET. Cancers, 15( 7), 1-36. doi:10.3390/cancers15072025
NLM
De Nardi AB, Gomes C de OM-S, Alves CEF, Paiva FN de, Linhares LCM, Carra GJU, Horta R dos S, Sueiro FAR, Jark PC, Nishiya AT, Vasconcellos CH de C, Ubukata R, Batschinski K, Sobral RA, Fernandes SC, Biondi LR, Strefezzi R de F, Matera JM, Rangel MMM, Anjos DS dos, Brunner CHM, Amorim RL, Cadrobbi KG, Cirillo JV, Martins MC, Reis Filho N de P, Lessa DFS, Portela R, Carneiro CS, Lucas SRR, Fukumasu H, Feliciano MAR, Quitzan JG, Dagli MLZ. Diagnosis, prognosis, and treatment of canine hemangiosarcoma: a review based on a consensus organized by the Brazilian Association of Veterinary Oncology, ABROVET [Internet]. Cancers. 2023 ; 15( 7): 1-36.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15072025
Vancouver
De Nardi AB, Gomes C de OM-S, Alves CEF, Paiva FN de, Linhares LCM, Carra GJU, Horta R dos S, Sueiro FAR, Jark PC, Nishiya AT, Vasconcellos CH de C, Ubukata R, Batschinski K, Sobral RA, Fernandes SC, Biondi LR, Strefezzi R de F, Matera JM, Rangel MMM, Anjos DS dos, Brunner CHM, Amorim RL, Cadrobbi KG, Cirillo JV, Martins MC, Reis Filho N de P, Lessa DFS, Portela R, Carneiro CS, Lucas SRR, Fukumasu H, Feliciano MAR, Quitzan JG, Dagli MLZ. Diagnosis, prognosis, and treatment of canine hemangiosarcoma: a review based on a consensus organized by the Brazilian Association of Veterinary Oncology, ABROVET [Internet]. Cancers. 2023 ; 15( 7): 1-36.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15072025
Artigo de periodico
Profile of MicroRNAs associated with death due to disease progression in metastatic papillary Thyroid Carcinoma patients (2023)
Leite, Ana Kober Nogueira ; Saito, Kelly Cristina ; Theodoro, Thérèse Rachell ; Pasini, Fátima Solange ; Camilo, Luana Perrone ; Rossetti, Carlos Augusto ; Cavalheiro, Beatriz Godoi ; Alves, Venancio Avancini Ferreira ; Kowalski, Luiz Paulo ; Kimura, Edna Teruko ; Matos, Leandro Luongo
Fonte: Cancers. Unidades: ICB, FM
Assuntos: BIOLOGIA CELULAR, MICRORNAS, NEOPLASIAS DA TIREOIDE, CARCINOMA PAPILAR, METÁSTASE NEOPLÁSICA, MUTAÇÃO GENÉTICA, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Ana Kober Nogueira et al. Profile of MicroRNAs associated with death due to disease progression in metastatic papillary Thyroid Carcinoma patients. Cancers, v. 15, n. 3, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15030869. Acesso em: 06 nov. 2024.
APA
Leite, A. K. N., Saito, K. C., Theodoro, T. R., Pasini, F. S., Camilo, L. P., Rossetti, C. A., et al. (2023). Profile of MicroRNAs associated with death due to disease progression in metastatic papillary Thyroid Carcinoma patients. Cancers, 15( 3), 1-12. doi:10.3390/cancers15030869
NLM
Leite AKN, Saito KC, Theodoro TR, Pasini FS, Camilo LP, Rossetti CA, Cavalheiro BG, Alves VAF, Kowalski LP, Kimura ET, Matos LL. Profile of MicroRNAs associated with death due to disease progression in metastatic papillary Thyroid Carcinoma patients [Internet]. Cancers. 2023 ; 15( 3): 1-12.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15030869
Vancouver
Leite AKN, Saito KC, Theodoro TR, Pasini FS, Camilo LP, Rossetti CA, Cavalheiro BG, Alves VAF, Kowalski LP, Kimura ET, Matos LL. Profile of MicroRNAs associated with death due to disease progression in metastatic papillary Thyroid Carcinoma patients [Internet]. Cancers. 2023 ; 15( 3): 1-12.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers15030869
Artigo de periodico
Vet-ICD-O-Canine-1, a system for coding canine neoplasms based on the human ICD-O-3.2 (2022)
Pinello, Katia ; Baldassarre, Valeria ; Steiger, Katja ; Paciello, Orlando; Pires, Isabel ; Laufer-Amorim, Renée ; Oevermann, Anna ; Niza-Ribeiro, João ; Aresu, Luca ; Rous, Brian ; Znaor, Ariana; Cree, Ian A; Guscetti, Franco ; Palmieri, Chiara ; Dagli, Maria Lúcia Zaidan
Fonte: Cancers. Unidade: FMVZ
Assuntos: CÃES, NEOPLASIAS EM ANIMAL, REGISTROS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINELLO, Katia et al. Vet-ICD-O-Canine-1, a system for coding canine neoplasms based on the human ICD-O-3.2. Cancers, v. 14, n. 6, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14061529. Acesso em: 06 nov. 2024.
APA
Pinello, K., Baldassarre, V., Steiger, K., Paciello, O., Pires, I., Laufer-Amorim, R., et al. (2022). Vet-ICD-O-Canine-1, a system for coding canine neoplasms based on the human ICD-O-3.2. Cancers, 14( 6), 1-14. doi:10.3390/cancers14061529
NLM
Pinello K, Baldassarre V, Steiger K, Paciello O, Pires I, Laufer-Amorim R, Oevermann A, Niza-Ribeiro J, Aresu L, Rous B, Znaor A, Cree IA, Guscetti F, Palmieri C, Dagli MLZ. Vet-ICD-O-Canine-1, a system for coding canine neoplasms based on the human ICD-O-3.2 [Internet]. Cancers. 2022 ; 14( 6): 1-14.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14061529
Vancouver
Pinello K, Baldassarre V, Steiger K, Paciello O, Pires I, Laufer-Amorim R, Oevermann A, Niza-Ribeiro J, Aresu L, Rous B, Znaor A, Cree IA, Guscetti F, Palmieri C, Dagli MLZ. Vet-ICD-O-Canine-1, a system for coding canine neoplasms based on the human ICD-O-3.2 [Internet]. Cancers. 2022 ; 14( 6): 1-14.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14061529
Artigo de periodico
A stochastic binary model for the regulation of gene expression to investigate responses to gene therapy (2022)
Giovanini, Guilherme ; Barros, Luciana R. C. ; Gama, Leonardo R. ; Tortelli Junior, Tharcisio Citrangulo ; Ramos, Alexandre Ferreira
Fonte: Cancers. Unidades: EACH, FM
Assuntos: NEOPLASIAS, BIOLOGIA MOLECULAR, REGULAÇÃO GÊNICA, EXPRESSÃO GÊNICA, DINÂMICA ESTOCÁSTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIOVANINI, Guilherme et al. A stochastic binary model for the regulation of gene expression to investigate responses to gene therapy. Cancers, v. 14, n. Ja 2022, p. 01-29, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14030633. Acesso em: 06 nov. 2024.
APA
Giovanini, G., Barros, L. R. C., Gama, L. R., Tortelli Junior, T. C., & Ramos, A. F. (2022). A stochastic binary model for the regulation of gene expression to investigate responses to gene therapy. Cancers, 14( Ja 2022), 01-29. doi:10.3390/cancers14030633
NLM
Giovanini G, Barros LRC, Gama LR, Tortelli Junior TC, Ramos AF. A stochastic binary model for the regulation of gene expression to investigate responses to gene therapy [Internet]. Cancers. 2022 ; 14( Ja 2022): 01-29.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14030633
Vancouver
Giovanini G, Barros LRC, Gama LR, Tortelli Junior TC, Ramos AF. A stochastic binary model for the regulation of gene expression to investigate responses to gene therapy [Internet]. Cancers. 2022 ; 14( Ja 2022): 01-29.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14030633
Artigo de periodico
Proteases and HPV-induced carcinogenesis (2022)
Vieira, Gabriel Viliod ; Santos, Fernanda Somera dos ; Lepique, Ana Paula ; Fonseca, Carol Kobori da ; Innocentini, Lara Maria Alencar Ramos ; Silva, Paulo Henrique Braz ; Quintana, Silvana Maria ; Sales, Katiuchia Uzzun
Fonte: Cancers. Unidades: ICB, FMRP, FO
Assuntos: IMUNOLOGIA, INFECÇÕES POR PAPILLOMAVIRUS, INFECÇÕES POR VÍRUS DE DNA, CARCINOGÊNESE, ENZIMAS PROTEOLÍTICAS, ATIVAÇÃO ENZIMÁTICA, NEOPLASIAS DO COLO UTERINO, NEOPLASIAS OROFARÍNGEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Gabriel Viliod et al. Proteases and HPV-induced carcinogenesis. Cancers, v. 14, n. 13, p. 1-25, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14133038. Acesso em: 06 nov. 2024.
APA
Vieira, G. V., Santos, F. S. dos, Lepique, A. P., Fonseca, C. K. da, Innocentini, L. M. A. R., Silva, P. H. B., et al. (2022). Proteases and HPV-induced carcinogenesis. Cancers, 14( 13), 1-25. doi:10.3390/cancers14133038
NLM
Vieira GV, Santos FS dos, Lepique AP, Fonseca CK da, Innocentini LMAR, Silva PHB, Quintana SM, Sales KU. Proteases and HPV-induced carcinogenesis [Internet]. Cancers. 2022 ; 14( 13): 1-25.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14133038
Vancouver
Vieira GV, Santos FS dos, Lepique AP, Fonseca CK da, Innocentini LMAR, Silva PHB, Quintana SM, Sales KU. Proteases and HPV-induced carcinogenesis [Internet]. Cancers. 2022 ; 14( 13): 1-25.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14133038
Artigo de periodico
Aerobic exercise training and in vivo akt activation counteract cancer cachexia by inducing a hypertrophic profile through eIF-2α modulation (2022)
Pereira, Marcelo Gomes ; Voltarelli, Vanessa Azevedo ; Tobias, Gabriel Cardial ; Souza, Lara de; Borges, Gabriela Silva ; Paixão, Ailma Oliveira da ; Bowen, Thomas Scott; Demasi, Marilene ; Miyabara, Elen Haruka ; Brum, Patricia Chakur
Fonte: Cancers. Unidades: EEFE, ICB
Assuntos: ANATOMIA, EXERCÍCIO FÍSICO, CAQUEXIA, MÚSCULO ESQUELÉTICO, PERDA DE MASSA, PERDA DE PESO, COMORBIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Marcelo Gomes et al. Aerobic exercise training and in vivo akt activation counteract cancer cachexia by inducing a hypertrophic profile through eIF-2α modulation. Cancers, v. 14, n. 1, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14010028. Acesso em: 06 nov. 2024.
APA
Pereira, M. G., Voltarelli, V. A., Tobias, G. C., Souza, L. de, Borges, G. S., Paixão, A. O. da, et al. (2022). Aerobic exercise training and in vivo akt activation counteract cancer cachexia by inducing a hypertrophic profile through eIF-2α modulation. Cancers, 14( 1), 1-20. doi:10.3390/cancers14010028
NLM
Pereira MG, Voltarelli VA, Tobias GC, Souza L de, Borges GS, Paixão AO da, Bowen TS, Demasi M, Miyabara EH, Brum PC. Aerobic exercise training and in vivo akt activation counteract cancer cachexia by inducing a hypertrophic profile through eIF-2α modulation [Internet]. Cancers. 2022 ; 14( 1): 1-20.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14010028
Vancouver
Pereira MG, Voltarelli VA, Tobias GC, Souza L de, Borges GS, Paixão AO da, Bowen TS, Demasi M, Miyabara EH, Brum PC. Aerobic exercise training and in vivo akt activation counteract cancer cachexia by inducing a hypertrophic profile through eIF-2α modulation [Internet]. Cancers. 2022 ; 14( 1): 1-20.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14010028
Artigo de periodico
Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms (2022)
Vicari, Hugo Passos ; Lima, Keli Cristina de ; Costa-Lotufo, Letícia Veras ; Machado Neto, João Agostinho
Fonte: Cancers. Unidades: ICB, FM
Assuntos: FARMACOLOGIA, LEUCEMIA, ANTINEOPLÁSICOS, MICROTÚBULOS, LEUCÓCITOS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICARI, Hugo Passos et al. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms. Cancers, v. 14, n. 24, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14246080. Acesso em: 06 nov. 2024.
APA
Vicari, H. P., Lima, K. C. de, Costa-Lotufo, L. V., & Machado Neto, J. A. (2022). Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms. Cancers, 14( 24), 1-15. doi:10.3390/cancers14246080
NLM
Vicari HP, Lima KC de, Costa-Lotufo LV, Machado Neto JA. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms [Internet]. Cancers. 2022 ; 14( 24): 1-15.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14246080
Vancouver
Vicari HP, Lima KC de, Costa-Lotufo LV, Machado Neto JA. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms [Internet]. Cancers. 2022 ; 14( 24): 1-15.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14246080
Artigo de periodico
Reproducibility of gene expression signatures in diffuse large B-cell lymphoma (2022)
Plaça, Jessica Rodrigues; Diepstra, Arjan; Los, Tjitske; Mendeville, Matías; Seitz, Annika; Lugtenburg, Pieternella J.; Zijlstra, Josée; Lam, King; Silva Junior, Wilson Araújo da ; Ylstra, Bauke; Jong, Daphne de; Berg, Anke van den; Nijland, Marcel
Fonte: Cancers. Unidade: FMRP
Assuntos: LINFOMA, EXPRESSÃO GÊNICA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PLAÇA, Jessica Rodrigues et al. Reproducibility of gene expression signatures in diffuse large B-cell lymphoma. Cancers, v. 14, n. 5, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14051346. Acesso em: 06 nov. 2024.
APA
Plaça, J. R., Diepstra, A., Los, T., Mendeville, M., Seitz, A., Lugtenburg, P. J., et al. (2022). Reproducibility of gene expression signatures in diffuse large B-cell lymphoma. Cancers, 14( 5), 1-15. doi:10.3390/cancers14051346
NLM
Plaça JR, Diepstra A, Los T, Mendeville M, Seitz A, Lugtenburg PJ, Zijlstra J, Lam K, Silva Junior WA da, Ylstra B, Jong D de, Berg A van den, Nijland M. Reproducibility of gene expression signatures in diffuse large B-cell lymphoma [Internet]. Cancers. 2022 ; 14( 5): 1-15.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14051346
Vancouver
Plaça JR, Diepstra A, Los T, Mendeville M, Seitz A, Lugtenburg PJ, Zijlstra J, Lam K, Silva Junior WA da, Ylstra B, Jong D de, Berg A van den, Nijland M. Reproducibility of gene expression signatures in diffuse large B-cell lymphoma [Internet]. Cancers. 2022 ; 14( 5): 1-15.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14051346
Artigo de periodico
Unraveling the risk factors and etiology of the canine oral mucosal melanoma: results of an epidemiological questionnaire, oral microbiome analysis and investigation of papillomavirus infection (2022)
Carvalho, Joyce Pires de ; Carrilho, Marcella Collaneri; Anjos, Denner Santos dos ; Hernandez, Carolina Dagli ; Sichero, Laura ; Dagli, Maria Lúcia Zaidan
Fonte: Cancers. Unidades: FMVZ, FCF
Assuntos: MELANOMA ANIMAL, PAPILLOMAVIRUS, CÃES, NEOPLASIAS OROFARÍNGEAS, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Joyce Pires de et al. Unraveling the risk factors and etiology of the canine oral mucosal melanoma: results of an epidemiological questionnaire, oral microbiome analysis and investigation of papillomavirus infection. Cancers, v. 14, n. 14, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14143397. Acesso em: 06 nov. 2024.
APA
Carvalho, J. P. de, Carrilho, M. C., Anjos, D. S. dos, Hernandez, C. D., Sichero, L., & Dagli, M. L. Z. (2022). Unraveling the risk factors and etiology of the canine oral mucosal melanoma: results of an epidemiological questionnaire, oral microbiome analysis and investigation of papillomavirus infection. Cancers, 14( 14), 1-15. doi:10.3390/cancers14143397
NLM
Carvalho JP de, Carrilho MC, Anjos DS dos, Hernandez CD, Sichero L, Dagli MLZ. Unraveling the risk factors and etiology of the canine oral mucosal melanoma: results of an epidemiological questionnaire, oral microbiome analysis and investigation of papillomavirus infection [Internet]. Cancers. 2022 ; 14( 14): 1-15.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14143397
Vancouver
Carvalho JP de, Carrilho MC, Anjos DS dos, Hernandez CD, Sichero L, Dagli MLZ. Unraveling the risk factors and etiology of the canine oral mucosal melanoma: results of an epidemiological questionnaire, oral microbiome analysis and investigation of papillomavirus infection [Internet]. Cancers. 2022 ; 14( 14): 1-15.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14143397
Artigo de periodico
Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we? (2022)
Fuziwara, Cesar Seigi ; Mello, Diego Claro de ; Kimura, Edna Teruko
Fonte: Cancers. Unidade: ICB
Assuntos: BIOLOGIA CELULAR, NEOPLASIAS DA TIREOIDE, CÉLULAS CULTIVADAS DE TUMOR, GENES, GENES, GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUZIWARA, Cesar Seigi e MELLO, Diego Claro de e KIMURA, Edna Teruko. Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we?. Cancers, v. 14, n. 3, p. 1-21, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14030844. Acesso em: 06 nov. 2024.
APA
Fuziwara, C. S., Mello, D. C. de, & Kimura, E. T. (2022). Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we? Cancers, 14( 3), 1-21. doi:10.3390/cancers14030844
NLM
Fuziwara CS, Mello DC de, Kimura ET. Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we? [Internet]. Cancers. 2022 ; 14( 3): 1-21.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14030844
Vancouver
Fuziwara CS, Mello DC de, Kimura ET. Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we? [Internet]. Cancers. 2022 ; 14( 3): 1-21.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers14030844
Artigo de periodico
gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly (2021)
Wildemberg, Luiz Eduardo; Henriques, Daniel; Elias, Paula Conde Lamparelli; Lima, Carlos Henrique de A.; Musolino, Nina R. de Castro; Camacho, Aline Helen Silva; Faria, Olivia; Nazato, Debora; Abucham, Julio; Vilar, Lucio; Mota, Jose Italo; Huayllas, Martha Katherine P.; Chimelli, Leila; Castro, Margaret de ; Kasuki, Leandro; Gadelha, Mônica R.
Fonte: Cancers. Unidade: FMRP
Assuntos: MUTAÇÃO GENÉTICA, ACROMEGALIA, SOMATOSTATINA, BIOMARCADORES, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILDEMBERG, Luiz Eduardo et al. gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly. Cancers, v. 13, n. 19, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13194857. Acesso em: 06 nov. 2024.
APA
Wildemberg, L. E., Henriques, D., Elias, P. C. L., Lima, C. H. de A., Musolino, N. R. de C., Camacho, A. H. S., et al. (2021). gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly. Cancers, 13( 19), 1-11. doi:10.3390/cancers13194857
NLM
Wildemberg LE, Henriques D, Elias PCL, Lima CH de A, Musolino NR de C, Camacho AHS, Faria O, Nazato D, Abucham J, Vilar L, Mota JI, Huayllas MKP, Chimelli L, Castro M de, Kasuki L, Gadelha MR. gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly [Internet]. Cancers. 2021 ; 13( 19): 1-11.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers13194857
Vancouver
Wildemberg LE, Henriques D, Elias PCL, Lima CH de A, Musolino NR de C, Camacho AHS, Faria O, Nazato D, Abucham J, Vilar L, Mota JI, Huayllas MKP, Chimelli L, Castro M de, Kasuki L, Gadelha MR. gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly [Internet]. Cancers. 2021 ; 13( 19): 1-11.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers13194857
Artigo de periodico
YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells (2021)
Cruzeiro, Gustavo Alencastro Veiga ; Magalhães, Taciani de Almeida; Sousa, Graziella Ribeiro de ; Silva, Ricardo Bonfim; Biagi Junior, Carlos Alberto Oliveira de ; Chagas, Pablo Ferreira das ; Queiroz, Rosane Gomes de Paula; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga ; Valera, Elvis Terci
Fonte: Cancers. Unidade: FMRP
Assuntos: MEDULOBLASTOMA, GENÔMICA, NEOPLASIAS, BIOMARCADORES, TERAPIA COMBINADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZEIRO, Gustavo Alencastro Veiga et al. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells. Cancers, v. 13, n. 24, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13246249. Acesso em: 06 nov. 2024.
APA
Cruzeiro, G. A. V., Magalhães, T. de A., Sousa, G. R. de, Silva, R. B., Biagi Junior, C. A. O. de, Chagas, P. F. das, et al. (2021). YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells. Cancers, 13( 24), 1-11. doi:10.3390/cancers13246249
NLM
Cruzeiro GAV, Magalhães T de A, Sousa GR de, Silva RB, Biagi Junior CAO de, Chagas PF das, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells [Internet]. Cancers. 2021 ; 13( 24): 1-11.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers13246249
Vancouver
Cruzeiro GAV, Magalhães T de A, Sousa GR de, Silva RB, Biagi Junior CAO de, Chagas PF das, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells [Internet]. Cancers. 2021 ; 13( 24): 1-11.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/cancers13246249

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos